India's Marksans Pharma rises after Q1 profit boost
** Shares of Marksans Pharma MARK.NS up 9.4% at 205.4
rupees, its steepest gain since July 24
** Pharmaceutical formulations maker's Q1 consol net profit
grew ~30%, rev up 18%
** Shares see busiest day in about 3 weeks, with over 3.2
mln shares traded
** Stock up 28% YTD, vs an 81% and 9% rise in peers Natco
Pharma NATP.NS and Mankind Pharma MNKI.NS , respectively
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg